Target intelligence / Profile preview

Usher syndrome type-2A protein (USH2A)

Target
USH2A
Molecular classification
Cell adhesion molecule, Extracellular matrix protein, Transmembrane protein
01

Overview

Usherin, encoded by the USH2A gene, is a large basement membrane-like transmembrane protein essential for the structural and functional integrity of sensory cells in the inner ear and the retina (UniProt Q9Y646). In the cochlea, it is a vital component of the protein complex forming the hair cell stereocilia ankle links, which are necessary for mechanotransduction and hearing (PubMed: 20301591). In the eye, usherin is localized to the photoreceptor periciliary membrane, where it facilitates the transport of essential proteins between the inner and outer segments (NIH: GeneReviews). Mutations in the USH2A gene are the most common cause of Usher syndrome, a condition characterized by combined hearing loss and progressive vision loss due to retinitis pigmentosa (PubMed: 33513348). Because the USH2A cDNA is too large for standard single-vector adeno-associated virus (AAV) gene replacement, therapeutic development has shifted toward antisense oligonucleotides (ASOs) like ultevursen, which aim to skip specific mutation-bearing exons to restore protein function (ClinicalTrials.gov: NCT03913169). Current clinical efforts focus on slowing the progression of retinal degeneration in patients with specific USH2A mutations.

Other names
UsherinUSH2US2Usher syndrome type IIa protein
02

Mechanism of action

Antisense oligonucleotide-mediated exon skipping to restore the reading frame and produce a functional truncated protein

03

Biological functions

Sensory perception of soundSensory perception of lightCell-cell adhesionMaintenance of photoreceptor cellsStructural integrity of the periciliary membraneIntracellular protein transport
04

Disease associations

Usher syndrome type IIARetinitis pigmentosa 39Autosomal recessive sensorineural hearing loss
05

Safety considerations

Intravitreal injection-related complications (e.g., endophthalmitis, retinal detachment)Cystoid macular edemaIntraocular inflammation or uveitisOff-target effects of RNA modulationLimited durability requiring repeated administration
06

Interacting drugs

Ultevursen (QR-421a)
07

Biomarkers

USH2A gene mutation statusEllipsoid zone (EZ) area on OCTBest-corrected visual acuity (BCVA)Electroretinogram (ERG) responseVisual field sensitivity

Beyond the preview

Go deeper on Usher syndrome type-2A protein (USH2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Usher syndrome type-2A protein (USH2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call